Estrogen receptor-α: Plasma membrane localization and functions

M. Marino, P. Ascenzi

Research output: Contribution to journalArticle

Abstract

The knowledge of the molecular mechanism by which estrogens exert pleiotropic functions in different tissues and organs has evolved rapidly during the past two decades. It is now well established that 17β-estradiol (E2) induces the transcriptional regulation of target gene expression upon binding to the intracellular estrogen receptor-α (ERα) or -β (ERβ). In addition E2 modulates cell functions through rapid non-genomic actions. Stimulation of G-proteins, Ca2+ influx as well as phospholipase C, ERK/MAPK, and PI3K/AKT activation occur within seconds to minutes upon E2 binding to a small population of ERα located at the plasma membrane. Several laboratories have recently examined the structural requirements for the localization and function(s) of plasma membrane ERα. We have shown that human ERα location at the plasma membrane and its interaction with caveolin-1 is mediated by S-palmitoylation of the Cys447 residue. Moreover, E2 also modulates Cys447 S-(de)palmitoylation enabling ERα association with signal transduction proteins (e.g. Src and G-proteins) in a cell context-related fashion. This leads to downstream signaling important for cell growth and survival. Here, the structural bases and mechanisms for ERα localization and action(s) are discussed along with potential implications for development of new drugs.

Original languageEnglish
Pages (from-to)281-289
Number of pages9
JournalImmunology, Endocrine and Metabolic Agents in Medicinal Chemistry
Volume6
Issue number3
Publication statusPublished - Jun 2006

Fingerprint

Estrogen Receptors
Cell Membrane
Lipoylation
GTP-Binding Proteins
Caveolin 1
Gene Expression Regulation
Type C Phospholipases
Phosphatidylinositol 3-Kinases
Estradiol
Signal Transduction
Cell Survival
Estrogens
Growth
Pharmaceutical Preparations
Population
Proteins

Keywords

  • Drug targeting
  • Estrogen receptor α
  • Plasma membrane location
  • Rapid non-genomic effects
  • S-palmitoylation

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Immunology and Allergy
  • Pharmacology

Cite this

Estrogen receptor-α : Plasma membrane localization and functions. / Marino, M.; Ascenzi, P.

In: Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry, Vol. 6, No. 3, 06.2006, p. 281-289.

Research output: Contribution to journalArticle

@article{a0912e7a739b4d2f8d3bf78bef28ab51,
title = "Estrogen receptor-α: Plasma membrane localization and functions",
abstract = "The knowledge of the molecular mechanism by which estrogens exert pleiotropic functions in different tissues and organs has evolved rapidly during the past two decades. It is now well established that 17β-estradiol (E2) induces the transcriptional regulation of target gene expression upon binding to the intracellular estrogen receptor-α (ERα) or -β (ERβ). In addition E2 modulates cell functions through rapid non-genomic actions. Stimulation of G-proteins, Ca2+ influx as well as phospholipase C, ERK/MAPK, and PI3K/AKT activation occur within seconds to minutes upon E2 binding to a small population of ERα located at the plasma membrane. Several laboratories have recently examined the structural requirements for the localization and function(s) of plasma membrane ERα. We have shown that human ERα location at the plasma membrane and its interaction with caveolin-1 is mediated by S-palmitoylation of the Cys447 residue. Moreover, E2 also modulates Cys447 S-(de)palmitoylation enabling ERα association with signal transduction proteins (e.g. Src and G-proteins) in a cell context-related fashion. This leads to downstream signaling important for cell growth and survival. Here, the structural bases and mechanisms for ERα localization and action(s) are discussed along with potential implications for development of new drugs.",
keywords = "Drug targeting, Estrogen receptor α, Plasma membrane location, Rapid non-genomic effects, S-palmitoylation",
author = "M. Marino and P. Ascenzi",
year = "2006",
month = "6",
language = "English",
volume = "6",
pages = "281--289",
journal = "Current Medicinal Chemistry: Immunology, Endocrine and Metabolic Agents",
issn = "1871-5222",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

TY - JOUR

T1 - Estrogen receptor-α

T2 - Plasma membrane localization and functions

AU - Marino, M.

AU - Ascenzi, P.

PY - 2006/6

Y1 - 2006/6

N2 - The knowledge of the molecular mechanism by which estrogens exert pleiotropic functions in different tissues and organs has evolved rapidly during the past two decades. It is now well established that 17β-estradiol (E2) induces the transcriptional regulation of target gene expression upon binding to the intracellular estrogen receptor-α (ERα) or -β (ERβ). In addition E2 modulates cell functions through rapid non-genomic actions. Stimulation of G-proteins, Ca2+ influx as well as phospholipase C, ERK/MAPK, and PI3K/AKT activation occur within seconds to minutes upon E2 binding to a small population of ERα located at the plasma membrane. Several laboratories have recently examined the structural requirements for the localization and function(s) of plasma membrane ERα. We have shown that human ERα location at the plasma membrane and its interaction with caveolin-1 is mediated by S-palmitoylation of the Cys447 residue. Moreover, E2 also modulates Cys447 S-(de)palmitoylation enabling ERα association with signal transduction proteins (e.g. Src and G-proteins) in a cell context-related fashion. This leads to downstream signaling important for cell growth and survival. Here, the structural bases and mechanisms for ERα localization and action(s) are discussed along with potential implications for development of new drugs.

AB - The knowledge of the molecular mechanism by which estrogens exert pleiotropic functions in different tissues and organs has evolved rapidly during the past two decades. It is now well established that 17β-estradiol (E2) induces the transcriptional regulation of target gene expression upon binding to the intracellular estrogen receptor-α (ERα) or -β (ERβ). In addition E2 modulates cell functions through rapid non-genomic actions. Stimulation of G-proteins, Ca2+ influx as well as phospholipase C, ERK/MAPK, and PI3K/AKT activation occur within seconds to minutes upon E2 binding to a small population of ERα located at the plasma membrane. Several laboratories have recently examined the structural requirements for the localization and function(s) of plasma membrane ERα. We have shown that human ERα location at the plasma membrane and its interaction with caveolin-1 is mediated by S-palmitoylation of the Cys447 residue. Moreover, E2 also modulates Cys447 S-(de)palmitoylation enabling ERα association with signal transduction proteins (e.g. Src and G-proteins) in a cell context-related fashion. This leads to downstream signaling important for cell growth and survival. Here, the structural bases and mechanisms for ERα localization and action(s) are discussed along with potential implications for development of new drugs.

KW - Drug targeting

KW - Estrogen receptor α

KW - Plasma membrane location

KW - Rapid non-genomic effects

KW - S-palmitoylation

UR - http://www.scopus.com/inward/record.url?scp=33746206601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746206601&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33746206601

VL - 6

SP - 281

EP - 289

JO - Current Medicinal Chemistry: Immunology, Endocrine and Metabolic Agents

JF - Current Medicinal Chemistry: Immunology, Endocrine and Metabolic Agents

SN - 1871-5222

IS - 3

ER -